MARRONE BIO INNOVATIONS INC - COM (MBII)

CUSIP: 57165B106

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
43,201,995
Share change
-2,774,897
Total reported value
$46,669,948
Price per share
$1.08
Number of holders
70
Value change
-$2,158,878
Number of buys
22
Number of sells
39

Quarterly Holders Quick Answers

What is CUSIP 57165B106?
CUSIP 57165B106 identifies MBII - MARRONE BIO INNOVATIONS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARRONE BIO INNOVATIONS INC - COM (MBII) as of Q1 2022

As of 31 Mar 2022, MARRONE BIO INNOVATIONS INC - COM (MBII) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,201,995 shares. The largest 10 holders included ARDSLEY ADVISORY PARTNERS LP, BlackRock Inc., VANGUARD GROUP INC, Shay Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, PRIMECAP MANAGEMENT CO/CA/, STATE STREET CORP, Allianz Asset Management GmbH, Ergoteles LLC, and NORTHERN TRUST CORP. This page lists 70 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.